Trending...
- Boston: SCHOOLS URGED TO REGISTER FOR THE BCYF SPELLING BEE
- Massachusetts: Governor Healey Announces Veterans Equality Review Board (VERB) to Support Veterans Discharged Under "Don't Ask, Don't Tell" Policy
- Sidow Sobrino Announces 12th Album, "Seminal"
Download
The current standard of care options for rebuilding deficient jawbone includes a variety of materials that require membranes and time consuming fixation devices. These products do not predictably maintain ridge volume which requires surgeons to undergo re-grafting in over 30% of clinical cases. TETRANITE eliminates the use of membranes and other fixation devices, when compared to the standard of care. Furthermore, TETRANITE resorbs fully while maintaining predictable ridge volume throughout the bone regeneration process. (Graphic: Business Wire)
LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc. heeft aangekondigd dat het een Fase II Small Business Innovation Research (SBIR) subsidie van $ 2 miljoen heeft ontvangen van het National Institute of Dental and Craniofacial Research (NIDCR), onderdeel van de National Institutes of Health (NIH). Met deze financiering (1R44DE032564-01) kan het bedrijf het preklinische onderzoek voltooien dat nodig is om dit product naar de klinische ontwikkelingsfase te brengen.
More on Boston Chron
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.
Contacts
Michael Tiedemann
mtiedemann@revbio.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Michael Tiedemann
mtiedemann@revbio.com
The current standard of care options for rebuilding deficient jawbone includes a variety of materials that require membranes and time consuming fixation devices. These products do not predictably maintain ridge volume which requires surgeons to undergo re-grafting in over 30% of clinical cases. TETRANITE eliminates the use of membranes and other fixation devices, when compared to the standard of care. Furthermore, TETRANITE resorbs fully while maintaining predictable ridge volume throughout the bone regeneration process. (Graphic: Business Wire)
- The current standard of care options for rebuilding deficient jawbone includes a variety of materials that require membranes and time consuming fixation devices. These products do not predictably maintain ridge volume which requires surgeons to undergo re-grafting in over 30% of clinical cases. TETRANITE eliminates the use of membranes and other fixation devices, when compared to the standard of care. Furthermore, TETRANITE resorbs fully while maintaining predictable ridge volume throughout the bone regeneration process. (Graphic: Business Wire)
LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc. heeft aangekondigd dat het een Fase II Small Business Innovation Research (SBIR) subsidie van $ 2 miljoen heeft ontvangen van het National Institute of Dental and Craniofacial Research (NIDCR), onderdeel van de National Institutes of Health (NIH). Met deze financiering (1R44DE032564-01) kan het bedrijf het preklinische onderzoek voltooien dat nodig is om dit product naar de klinische ontwikkelingsfase te brengen.
More on Boston Chron
- Jennifer Steffens, PE Joins Opti Software for Stormwater Solutions as Vice President of Marketing
- Massachusetts Selected to Host ARPA-H Hub as Part of Nationwide Health Innovation Network
- Boston: Affordable Homeownership Opportunity in Dorchester
- Boston: Latest Updates from the Mayor's Office of Housing: September 22, 2023
- Massachusetts: Governor Healey Creates Commission to Accelerate Siting and Permitting of Clean Energy Infrastructure
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.
Contacts
Michael Tiedemann
mtiedemann@revbio.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Contacts
Michael Tiedemann
mtiedemann@revbio.com
Filed Under: Business
0 Comments
Latest on Boston Chron
- New Study Finds Wide Disparities in Bicycle Safety Across U.S. Cities
- Free Archery Classes for Adults and Teens in Boston
- Boston: Mayor Michelle Wu Appoints Mary Skelton Roberts to the MBTA Board of Directors
- Gaslight Studios Announces Acceptance Into Maestro Management Consulting Consortium
- Wellsboro, Pennsylvania Named Ninth Best Fall Town in the U.S. for Foliage
- Actionstep Acquires North American Legal Accounting Platform Soluno
- Boston: October is Italian-American Heritage Month
- RelyMD Bolsters its Telehealth Platform with Mental Health Services via CuraLinc Partnership
- Announcing INVIDICUM, the latest novel by Michael Brodsky
- Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo Soldiers
- Knobull Makes Sure That Job Seekers Stand Out In The Crowded Market
- AMERICAST Provides PreCast Pads to Charge Stations
- Boston Area Oom Yung Doe Martial Arts Schools Host the Master Level Teaching Team
- Massachusetts: Governor Healey Orders Statewide Maternal Health Review to Ensure Equitable Care in All Communities
- Massachusetts: Healey-Driscoll Administration Secures More Than $108 Million for Train Corridor Improvements Between Springfield and Worcester
- Sheila Stubbs Taylor of Detroit music royalty is "Chasing" on new single
- Sidow Sobrino Announces 12th Album, "Seminal"
- Boston Public Health Commission Encourages People to Get the Flu Shot Ahead of Flu Season
- Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
- Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex